| Teva Pharma AG - Palonosetron-Teva 0.25 mg/5 ml, Injektionslösung | | 68671 | | 01 | | Palonosetron-Teva 0.25 mg/5 ml | | Injektionslösung | | A04AA05 | | Palonosetron | | 08.07.2022 | | |
| | Composition | | palonosetronum 0.25 mg ut palonosetroni hydrochloridum, mannitolum, dinatrii edetas, acidum citricum monohydricum, natrii citras dihydricus, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 5 ml corresp., natrium 5,8 mg. | | Packungsbestandteile | | Injection solution | | | | | | | | Active Agent | Dose |
|---|
| Palonosetrone | 0.25mg / 5ml |
| | BAG: Active Agent | Dose |
|---|
| Palonosetrone | 0.25 mg |
| | | | Inactive agents |
|---|
| Citric Acid Monohydrate | | Acidum Hydrochloridum | | Dinatrii Edetas | | Mannitol | | Natrii Citras Dihydricus | | Sodium Hydroxide |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | 40.77 | 60.75 | B | SL | No |
|
|
